Benefits of the next comparative research were being noted by Flinn et al. It is a phase III randomized Intergroup trial comparing FC program vs . FAMP by yourself in 278 patients receiving their very first chemotherapy routine for B-CLL. Dosages of FC agenda had been similar to the initial https://andrewk777doz1.sunderwiki.com/user